Nikon Aims For $1.2 Billion Medical Optics Business In Four Years
This article was originally published in PharmAsia News
Nikon has set aside more than $280 million from its camera profits to invest in medical start-ups that could help it develop new products more quickly and build a $1.2 billion business by the end of fiscal year 2016.
You may also be interested in...
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.
The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.
Pfizer’s efforts to circumvent two US patents shielding Par’s Adrenalin (epinephrine) have again ended in failure, following a ruling by the US Court of Appeals for the Federal Circuit.